Insight Molecular Diagnostics shares fall 18.8% in after-hours trading following public offering announcement
IMDX Insight Molecular Diagnostics Inc
$1.77 -4.84%
View chart & analysis → - 1Insight Molecular Diagnostics Inc shares fell 18.8% in Monday after-hours trading.
- 2Insight Molecular Diagnostics Inc announced a public offering of common stock and fractional warrants.
- 3Insight Molecular Diagnostics Inc recorded revenue of $560,000 in the third quarter of 2026.
So what's the key point?
Insight Molecular Diagnostics announced it will issue new shares. Following this news, the stock price fell 18.8% in after-hours trading.
Source Associated Press +2 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.